Fundraising Fox

Bilayer Therapeutics

Cambridge, US · Founded 2020 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CT
Carlo Traverso GiovanniDirector
JK
Joshua KorzenikDirector
TA
Thomas A. ColletExecutive Officer, Director
RL
Robert LangerDirector

Investors · 1

Kendall Capital PartnersreportedBostonvia Robert Langer · board

Reported raises · per SEC filings

Form D private placements
▶$300KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua KorzenikDirector
  • Thomas A. ColletExecutive Officer, Director
  • Robert LangerDirector
  • Huang Yen-ChenDirector
  • David ZhuDirector
  • Carlo Giovanni TraversoDirector
Offering amount
$1M
Amount sold
$300K
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert LangerDirector
  • Carlo Traverso GiovanniDirector
  • Joshua KorzenikDirector
  • Thomas A. ColletExecutive Officer, Director
Offering amount
$3.6M
Amount sold
$2M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.